These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
697 related items for PubMed ID: 30169897
1. Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's disease. Chahine LM, Dos Santos C, Fullard M, Scordia C, Weintraub D, Erus G, Rosenthal L, Davatzikos C, McMillan CT. Eur J Neurol; 2019 Feb; 26(2):246-e18. PubMed ID: 30169897 [Abstract] [Full Text] [Related]
2. White matter hyperintensities are not associated with cognitive decline in early Parkinson's disease - The DeNoPa cohort. Hanning U, Teuber A, Lang E, Trenkwalder C, Mollenhauer B, Minnerup H. Parkinsonism Relat Disord; 2019 Dec; 69():61-67. PubMed ID: 31678722 [Abstract] [Full Text] [Related]
8. White matter hyperintensities are linked to future cognitive decline in de novo Parkinson's disease patients. Dadar M, Zeighami Y, Yau Y, Fereshtehnejad SM, Maranzano J, Postuma RB, Dagher A, Collins DL. Neuroimage Clin; 2018 Dec; 20():892-900. PubMed ID: 30292088 [Abstract] [Full Text] [Related]
9. White Matter Hyperintensities and Mild Cognitive Impairment in Parkinson's Disease. Mak E, Dwyer MG, Ramasamy DP, Au WL, Tan LC, Zivadinov R, Kandiah N. J Neuroimaging; 2015 Dec; 25(5):754-60. PubMed ID: 25753576 [Abstract] [Full Text] [Related]
10. Influence of diabetes mellitus on longitudinal atrophy and cognition in Parkinson's disease. Ong M, Foo H, Chander RJ, Wen MC, Au WL, Sitoh YY, Tan L, Kandiah N. J Neurol Sci; 2017 Jun 15; 377():122-126. PubMed ID: 28477681 [Abstract] [Full Text] [Related]
11. [Association of age-related white matter hyperintensity with brain atrophy and cognitive impairment in patients with Parkinson's disease]. Chen HM, Zhang MM, Wang YL. Zhonghua Yi Xue Za Zhi; 2020 Nov 24; 100(43):3397-3401. PubMed ID: 33238668 [Abstract] [Full Text] [Related]
12. Cognitive and motor correlates of grey and white matter pathology in Parkinson's disease. Dadar M, Gee M, Shuaib A, Duchesne S, Camicioli R. Neuroimage Clin; 2020 Nov 24; 27():102353. PubMed ID: 32745994 [Abstract] [Full Text] [Related]
14. Periventricular white matter hyperintensity burden and cognitive impairment in early Parkinson's disease. Huang X, Wen MC, Ng SY, Hartono S, Chia NS, Choi X, Tay KY, Au WL, Chan LL, Tan EK, Tan LC. Eur J Neurol; 2020 Jun 24; 27(6):959-966. PubMed ID: 32124496 [Abstract] [Full Text] [Related]
15. Cerebral white matter hyperintensity in Parkinson's disease: a major risk factor for mild cognitive impairment. Kandiah N, Mak E, Ng A, Huang S, Au WL, Sitoh YY, Tan LC. Parkinsonism Relat Disord; 2013 Jul 24; 19(7):680-3. PubMed ID: 23623194 [Abstract] [Full Text] [Related]
16. Progression of subcortical atrophy in mild Parkinson's disease and its impact on cognition. Foo H, Mak E, Yong TT, Wen MC, Chander RJ, Au WL, Sitoh YY, Tan LC, Kandiah N. Eur J Neurol; 2017 Feb 24; 24(2):341-348. PubMed ID: 27943468 [Abstract] [Full Text] [Related]
20. Microstructural Connectivity is More Related to Cognition than Conventional MRI in Parkinson's Disease. Lee YH, Lee WJ, Chung SJ, Yoo HS, Jung JH, Baik K, Sohn YH, Seong JK, Lee PH. J Parkinsons Dis; 2021 Aug 24; 11(1):239-249. PubMed ID: 33074193 [Abstract] [Full Text] [Related] Page: [Next] [New Search]